Scaleable Life Sciences Forward Ventures is a seasoned life-sciences venture capital firm with over 50 portfolio companies and more than $500 million under management, indicating ongoing fund activity and potential for collaboration on financings, co-investments, and strategic partnerships.

US Focus with Europe Interest Active investment across the United States with selective European opportunities, presenting doors to cross-border deals, syndicated rounds, and potential introductions to European biotech and healthtech startups seeking US capital and strategic buyers.

Recent Deployments Notable past and recent investments include Xanadu and SpotQA, signaling openness to diverse life-science subsectors and early to growth-stage opportunities, suggesting targets for outreach in seed to growth rounds aligned with Forward’s Fund V strategy.

Operational Readiness Strong emphasis on entrepreneurship and operational experience within the investment team, which can be leveraged to offer portfolio value adds such as go-to-market support, clinical regulatory strategy, and corporate development partnerships to attract deal flow.

Funding Milestones Revenue range and fund size imply a healthy deal flow and capital availability for co-investments, strategic financings, or follow-on rounds, making Forward Ventures a viable partner for mid-stage biotech and health-care tech opportunities seeking capital and credibility.